Dark
Light
CNBX will enter the cancer immunotherapy market after acquiring a controlling interest in TaGeza Biopharma
CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related medicine, announced today that…
